• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

SEC Sues Elon Musk for Delayed Disclosure of Twitter Stock Purchase

user avatar

by Giorgi Kostiuk

a year ago


The United States Securities and Exchange Commission (SEC) has filed a lawsuit against Elon Musk for failing to timely disclose his acquisition of Twitter (renamed X) stock.

Timely Disclosure

According to the complaint, Musk began accumulating Twitter stock in early 2022 and crossed the 5% threshold by March 14, which required disclosure. However, he disclosed his ownership only 11 days later, on April 4, 2022, after his stake had exceeded 9%. The SEC claims this allowed Musk to continue purchasing shares at "artificially low prices," leading to unjust enrichment of at least $150 million.

Investors who sold Twitter common stock during this period did so at artificially low prices and thus suffered substantial economic harm.

Elon Musk's Reaction

In a statement on platform X, Musk responded to the suit, describing the SEC as a "totally broken organization."

Twitter Acquisition and Changes

Musk initiated the acquisition of Twitter in April 2022 and completed it in October for $44 billion. He implemented changes to the platform, including account monetization, audio-video calls, an in-app AI chatbot, and long-form texts.

The SEC's lawsuit against Elon Musk for delayed disclosure of Twitter stock highlights the importance of adhering to federal securities laws to prevent unjust enrichment.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.